We are extremely excited to be a finalist at the Thames Valley Tech & Innovation Awards this year. The category we are up for is “Life Sciences & Health Tech Company of the Year”
LATEST NEWS
- Neuro-Bio Featured in Webinar on Synthetic Binders in Diagnostics and Molecular Biology
- New Publication: Evaluating Monoclonal Antibodies in Alzheimer’s Disease Research
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures